Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial (vol 292, pg 696, 2004)

Publication | Closed Access

Citations

References

2006

Year

A. Michael Lincoff, NS Kleiman, Kereiakes Dj, Frederick Feit, JA Bittl, J. Daniel Jackman, Sarembock Ij, DJ Cohen, Doug Spriggs, Ramin Ebrahimi,

Unknown Venue

Percutaneous Coronary InterventionReplace-2 Randomized TrialGlycoprotein Iib/iiia BlockadeCardiovascular DiseaseVol 292Cardiovascular PharmacologyPharmacotherapyAcute Myocardial InfarctionMedicineAnticoagulantCardiologyCoronary Artery DiseaseAnesthesiology